findmyKOL
Clinical trialNCT01419158CompletedObservational

Prevalence of Alpha-1 Antitrypsin Deficiency in Chronic Obstructive Pulmonary Disease (COPD)

SponsorAlpha-1 FoundationEnrollment3,457Alpha-1 Antitrypsin DeficiencyChronic Obstructive Pulmonary Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Alpha-1 antitrypsin deficiency (AATD) is considered a rare genetic cause of chronic obstructive pulmonary disease (COPD) and liver disease. Recent data has suggested that AATD is not as rare as originally thought and undetected AATD may account for COPD in some patients. This study was designed to evaluate the frequency of undetected AATD in a population reporting to academic pulmonary function testing facilities who meet criteria for the diagnosis of COPD. All individuals meeting GOLD criteria for COPD will be consented and offered free testing for AATD. The results will help identify the percent of those with COPD who have undetected AATD.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Puerto Rico
  • San Juan City Hospital

    Centro Medico Metropolitano, San Juan, Puerto Rico

United States
  • University of California Los Angeles

    Los Angeles, California, United States

  • National Jewish Medical and Research Center

    Denver, Colorado, United States

  • University of Florida (gainesville)

    Gainesville, Florida, United States

  • University of Florida (jacksonville)

    Jacksonville, Florida, United States

  • Miami Va Medical Center

    Miami, Florida, United States

  • University of Miami

    Miami, Florida, United States

  • Cleveland Clinic Florida

    Weston, Florida, United States

  • Emory Crawford Long Hospital

    Atlanta, Georgia, United States

  • Emory University

    Atlanta, Georgia, United States

  • Atlanta Va Medical Center

    Decatur, Georgia, United States

  • University of Chicago

    Chicago, Illinois, United States

  • Mayo Clinic Rochester

    Rochester, Minnesota, United States

  • St. Luke'S-Roosevelt Hospital Center

    New York, New York, United States

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina, United States

  • the Cleveland Clinic Foundation

    Cleveland, Ohio, United States

  • Oregon Health & Science University

    Portland, Oregon, United States

  • Medical University of South Carolina

    Charleston, South Carolina, United States

  • University of Texas Health Science Center at Tyler

    Tyler, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2008
Primary completion
31 Jan 2010
Completion
31 Jan 2010
Last update posted
19 Jan 2012
Registered enrollment
3,457
Registry id
NCT01419158

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.